Zoltero 4 mg Injection

Zoltero 4Mg Injection

*To be consumed as directed by physician.

Therapies:

Supportive

Composition:

Zoledronic acid (4 mg)

About Zoltero 4Mg Injection

Zoltero 4 mg Injection contains Zoledronic Acid 4 mg, a bisphosphonate medicine that helps strengthen bones and reduce excessive bone breakdown. It is prescribed for the treatment of hypercalcemia (high blood calcium levels), osteoporosis, and certain bone complications associated with cancer, as advised by a physician. Zoledronic Acid works by inhibiting osteoclasts, the cells responsible for bone resorption, thereby helping maintain bone density, reducing the risk of fractures, and lowering elevated calcium levels in the blood. Zoltero is administered only under medical supervision as part of a comprehensive treatment plan that may include calcium, vitamin D supplementation, dietary modifications, and regular monitoring.

Zoltero 4Mg Injection

*To be consumed as directed by physician.


Usage Instructions

  • Zoltero 4 mg Injection should be administered only by a qualified healthcare professional.
  • The dose, frequency, and duration depend on the medical condition being treated, kidney function, and your doctor's assessment.
  • Drink plenty of fluids before receiving the injection unless otherwise advised, as adequate hydration helps reduce the risk of kidney complications.
  • Your doctor may recommend calcium and vitamin D supplements, regular kidney function tests, blood calcium monitoring, and bone mineral density (BMD) assessments during treatment.
  • Do not miss scheduled appointments or discontinue treatment without consulting your physician.

  • Benefits and Use

  • Zoltero 4 mg Injection is used to treat hypercalcemia associated with malignancy, osteoporosis, and bone complications related to certain cancers.
  • It helps reduce excessive bone breakdown, maintain bone mineral density, strengthen bones, and lower the risk of fractures.
  • In patients with hypercalcemia, it effectively lowers elevated blood calcium levels.
  • In osteoporosis, regular treatment helps preserve bone strength and reduce fracture risk.
  • When used in cancer patients, it helps manage bone-related complications and supports overall bone health as part of comprehensive medical care.

  • Safety Information

  • Pregnancy:
  • Zoltero 4 mg Injection should not be used during pregnancy unless specifically recommended by your doctor after carefully evaluating the benefits and risks.
  • Breastfeeding:
  • Avoid use during breastfeeding unless advised by your physician.
  • Alcohol:
  • Consult your doctor regarding alcohol consumption, as excessive alcohol intake may increase bone loss.
  • Kidney Disorders:
  • Use with caution in patients with kidney disease. Kidney function should be assessed before each dose, and dose adjustments may be required. Adequate hydration is important before treatment.
  • Liver Disorders:
  • Limited information is available regarding use in liver disease; consult your doctor before treatment.
  • Low Calcium Levels:
  • Existing hypocalcemia should be corrected before starting therapy.
  • Dental Care:
  • Rarely, Zoledronic Acid may cause osteonecrosis of the jaw. Maintain good oral hygiene, undergo regular dental check-ups, and inform your doctor if you develop jaw pain, swelling, or delayed healing after dental procedures.
  • Driving:
  • The injection may cause dizziness or fatigue in some patients. Avoid driving or operating machinery if affected.

  • Ingredients

    Zoledronic Acid 4 mg

    How to Use

  • Zoltero 4 mg Injection is administered as an intravenous (IV) infusion, usually over at least 15 minutes, by a doctor or trained healthcare professional.
  • Do not self-administer.
  • Follow your doctor's instructions regarding hydration, calcium supplementation, and follow-up laboratory investigations before and after treatment.

  • Storage Information

  • Store below 30°C, protected from direct sunlight.
  • Do not freeze.
  • Keep the vial in its original packaging until use.
  • Store out of reach of children.
  • Once prepared or diluted, the solution should be stored and used according to the manufacturer's instructions and healthcare facility protocols.
  • Do not use after the expiry date.